StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CLBT

Cellebrite DI Ltd.

CLBT Nasdaq Services-Prepackaged Software EDGAR ↗
$10.93
-0.14 -1.26%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$2.73B
Revenue (TTM) ⓘ
$476M
Net income (TTM) ⓘ
$78.3M
EPS (TTM) ⓘ
$0.31
P/E ratio ⓘ
35.3
Dividend yield ⓘ
—
Free cash flow ⓘ
$160M
Cash ⓘ
$124M
Total assets ⓘ
$939M
Gross margin ⓘ
84.2%
52-week range ⓘ
$9.58 – $19.98

AI briefing

from the latest 10-K, 10-Q and 8-K events

Cellebrite DI Ltd. is an Israel-based provider of AI-powered digital investigative and intelligence software and services for legally sanctioned investigations, listed on Nasdaq under the ticker CLBT.

What they do

Cellebrite develops and sells software and services used by law enforcement, government and other authorized organizations to collect, analyze and manage digital data from mobile devices, computers and the cloud. Its solutions support the full digital investigation lifecycle, from data extraction to intelligence analysis. The company is incorporated in Israel and its ordinary shares trade on the Nasdaq Global Market.

Revenue drivers

  • Digital investigative software and services — Cellebrite's primary business is subscription and perpetual software licenses for digital forensics and intelligence gathering, sold to law enforcement and government agencies worldwide. This is the core revenue source, though specific segment breakdowns are not provided in the excerpts.

Recent performance

Revenue grew to $475.7 million in 2025, up from $401.2 million in 2024 and $246.2 million in 2021. Net income swung to $78.3 million in 2025 after losses of $283.0 million in 2024 and $81.1 million in 2023, with diluted EPS of $0.31. Operating cash flow reached $173.5 million in 2025, the highest in the past five years. The balance sheet at December 31, 2025 showed total assets of $938.9 million, total liabilities of $454.5 million, and shareholders' equity of $484.3 million, including $124.5 million in cash and equivalents.

Strategy

Cellebrite describes itself as a leading provider of AI-powered digital investigative and intelligence solutions. The filing excerpts do not contain specific details on strategic initiatives, investments, or priorities beyond the company's general positioning statement. No forward-looking guidance or specific strategic plans are included in the provided material.

Risks

  • Customer concentration and regulatory dependence — The company's sales to law enforcement and government agencies are subject to budget cycles, political changes, and legal restrictions that could reduce demand.
  • Technology and data privacy compliance — Its digital investigation tools operate in sensitive legal and privacy contexts, exposing it to evolving regulations and potential misuse concerns.
  • Competition and rapid technical change — The digital forensics market is competitive and requires continuous innovation to maintain relevance against new extraction and analysis technologies.
  • Geopolitical and operational risks — As an Israeli company, Cellebrite faces risks from regional instability and potential restrictions on international sales or operations.

Outlook

The provided excerpts do not contain management guidance, forward-looking targets, or specific outlook statements for future periods. Revenue and profitability trends are positive through 2025, but no formal projections are included.

Recent SEC filings

40 most recent
Annual, quarterly & current reports